Yves Benoit
Overview
Explore the profile of Yves Benoit including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
85
Citations
1816
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
De Smedt R, Peirs S, Morscio J, Matthijssens F, Roels J, Reunes L, et al.
Haematologica
. 2018 Aug;
104(1):e17-e20.
PMID: 30076176
No abstract available.
12.
Milani G, Matthijssens F, Van Loocke W, Durinck K, Roels J, Peirs S, et al.
Br J Haematol
. 2018 Jun;
185(1):169-174.
PMID: 29938777
No abstract available.
13.
Mondelaers V, Suciu S, De Moerloose B, Ferster A, Mazingue F, Plat G, et al.
Haematologica
. 2017 Jul;
102(10):1727-1738.
PMID: 28751566
Asparaginase is an essential component of combination chemotherapy for childhood acute lymphoblastic leukemia and non-Hodgkin lymphoma. The value of asparaginase was further addressed in a group of non-very high-risk patients...
14.
Caes L, Goubert L, Devos P, Verlooy J, Benoit Y, Vervoort T
Pain Med
. 2017 Feb;
18(2):275-282.
PMID: 28204723
Objective: Caregivers’ pain estimations may have important implications for pediatric pain management decisions. Affective responses elicited by facing the child in pain are considered key in understanding caregivers’ estimations of...
15.
Ghazavi F, De Moerloose B, Van Loocke W, Wallaert A, Helsmoortel H, Ferster A, et al.
Oncotarget
. 2016 Sep;
7(45):73769-73780.
PMID: 27650541
Overwhelming evidence indicates that long non-coding RNAs have essential roles in tumorigenesis. Nevertheless, their role in the molecular pathogenesis of pediatric B-cell precursor acute lymphoblastic leukemia has not been extensively...
16.
Sleurs C, Lemiere J, Vercruysse T, Nolf N, Van Calster B, Deprez S, et al.
Psychooncology
. 2016 Jun;
26(4):508-514.
PMID: 27246629
Background: In childhood acute lymphoblastic leukemia (ALL), radiotherapy for CNS prophylaxis is not used in frontline therapy anymore. Standard treatment for ALL nowadays consists of polychemotherapy. Therefore, assessment of potential...
17.
Helsmoortel H, De Moerloose B, Pieters T, Ghazavi F, Bresolin S, Cave H, et al.
Haematologica
. 2016 Mar;
101(6):e240-4.
PMID: 26969084
No abstract available.
18.
Helsmoortel H, Bresolin S, Lammens T, Cave H, Noellke P, Caye A, et al.
Blood
. 2015 Dec;
127(9):1163-72.
PMID: 26712910
Juvenile myelomonocytic leukemia (JMML) is a rare and aggressive stem cell disease of early childhood. RAS activation constitutes the core component of oncogenic signaling. In addition, leukemic blasts in one-fourth...
19.
Bauters T, Bordon Cueto De Braem V, Schelstraete P, Van Lancker S, Laureys G, Benoit Y, et al.
Eur J Oncol Nurs
. 2015 Dec;
21:212-4.
PMID: 26645948
Purpose: Protective immunity to vaccine preventable infectious diseases might be lost over time following hematopoietic stem cell transplantation (HSCT). Limited data are available on the appropriate follow-up of vaccination schedules...
20.
Simon P, Suciu S, Clappier E, Cave H, Sirvent N, Plat G, et al.
Ann Hematol
. 2015 Oct;
95(1):93-103.
PMID: 26455579
Acute lymphoblastic leukemia of T cell lineage (T-ALL) is an aggressive malignant disease which accounts for 15 % of childhood ALL. T(11;14) is the more frequent chromosomal abnormality in childhood...